Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Legal costs behind Merck, GlaxoSmithKline losses in 4Q
Bizjournals.com
Thursday, February 3, 2011 - 6:12pm
tags:
legal, Merck, earnings, GSK
FDA Rejection Would Take Isis Stock Down
Seeking Alpha
Thursday, February 3, 2011 - 11:47am
tags:
FDA, mipomersen, Orexigen, Contrave, Isis Pharmaceuticals
Novo Nordisk Passes This Key Test
Motley Fool
Thursday, February 3, 2011 - 11:17am
tags:
Novo Nordisk
Allergan - Upgrades & Downgrades
TheStreet.com
Thursday, February 3, 2011 - 11:16am
tags:
Allergan
Optimer Gets NEJM Power
Forbes
Thursday, February 3, 2011 - 11:10am
tags:
New England Journal of Medicine, Optimer, fidaxomicin, Clostridium Difficile
Pfizer's Newest Acquisition Target
Motley Fool
Thursday, February 3, 2011 - 10:33am
tags:
Pfizer, M&A, Clinical Data, Dendreon, Amarin
Glaxo posts Q4 loss on Avandia charge
Yahoo/AP
Thursday, February 3, 2011 - 10:31am
tags:
GSK, earnings
Takeda Says Nine-Month Profit Falls on Prevacid, Yen
Bloomberg
Thursday, February 3, 2011 - 10:10am
tags:
earnings, Takeda
Pfizer Geysers
WSJ Online
Thursday, February 3, 2011 - 10:09am
tags:
Pfizer
Merck swings to a fourth-quarter loss
Marketwatch
Thursday, February 3, 2011 - 10:08am
tags:
Merck, earnings
5 Breakthrough Drugs for 2011
Barron's
Thursday, February 3, 2011 - 10:06am
tags:
Benlysta, Human Genome Sciences, GSK, ipilimumab, Bristol-Myers Squibb, Vertex Pharmaceuticals, JNJ, Telaprevir, Novartis, Incyte, INCB-18424, Xarelto, Bayer
Novo Confirms Potential in New Insulin but Challenges Remain
Seeking Alpha
Thursday, February 3, 2011 - 9:54am
tags:
Novo Nordisk, diabetes, insulin, degludec
Merck’s Gardasil Prevents HPV Infection, Genital Warts in Men
Bloomberg
Thursday, February 3, 2011 - 9:53am
tags:
Merck, Gardasil, HPV, genital warts
Two Companies Spending Billions to Buy Back Stock
Seeking Alpha
Thursday, February 3, 2011 - 9:50am
tags:
AstraZeneca, stock buyback
Mannkind Shares Popped: What You Need to Know
Motley Fool
Wednesday, February 2, 2011 - 5:22pm
tags:
Afrezza, inhaled insulin, MannKind
Botox, eye drug sales boost Allergan 4Q profit
Yahoo/AP
Wednesday, February 2, 2011 - 5:21pm
tags:
Allergan, profits
Novo Nordisk Q4 profits jump but outlook lowered
Yahoo/AP
Wednesday, February 2, 2011 - 5:18pm
tags:
earnings, Novo Nordisk
Sitting With Pfizer’s New Chief
Forbes
Wednesday, February 2, 2011 - 3:17pm
tags:
Pfizer, Pharma CEOs, Ian Read
Earnings Preview: Merck
Seeking Alpha
Wednesday, February 2, 2011 - 3:14pm
tags:
Merck, earnings
Pfizer & Merck Mega Mergers Disappoint
Minyanville
Wednesday, February 2, 2011 - 3:10pm
tags:
M&A, Pfizer, Merck, Wyeth, Schering Plough

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.